AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and ...

AstraZeneca has revealed ... This means the new R&D headquarters – combined with AZ's other research centres in Gaithersburg in the US (where biologics division MedImmune is located) and ...

AstraZeneca has revealed plans to set up a new ... Boston and Cambridge are a life sciences hotspot in the US, home to more than 1,000 R&D-based biotechnology companies, with Kendall Square ...

AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending ...

Astra headquarters and its main share listing ... about switching its primary stock market listing to the US'. He added: 'Losing AstraZeneca from the FTSE 100 would be a blow for the stock ...

(Reuters) -AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and Manufacturers of America (PhRMA) said on Tuesday. This ...